Yi Larson, EVP & Chief Financial Officer at Turning Point Therapeutics, Inc. (TPTX), bought 2,222 shares at $45.00 ($100K) on 2019-09-10, disclosed to the SEC on 2019-09-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.